Pfizer’s Hospira, Iatric Systems ink infusion pump interoperability deal

December 19, 2016 By Fink Densford Leave a Comment

Pfizer (NYSE:PFE) said today that its Hospira subsidiary and healthcare IT group Iatric Systems inked a partnership deal to develop interoperability between Hospira’s smart infusion pumps and Iatric’s Accelero Connect integration software.

The 2 companies said they are currently piloting smart-pump EMR interoperability at an undisclosed US hospital.

“Hospira is proud to partner with Iatric Systems to make IV-EMR interoperability available to the hundreds of hospitals where Iatric Systems performs integration. After already becoming the first smart pump vendor to successfully integrate with three major EMR platforms, we are excited to add another major EMR system to the list once this pilot site goes live,” Hospira prez Julie Sawyer-Montgomery said in a press release

The project aims to provide 2-way communication between the system to enable pump programming automation with validated EMR medication orders, as well as documenting medication administrations into the patient’s EMR.

“Smart pump-EMR integration can help save lives and money. Simply put, it’s the right thing to do. On the clinical side, we’re sending IV medication orders from the EMR to the infusion pump, which significantly minimizes the chance of human errors and helps improve patient outcomes. On the financial side, we’re sending start times, stop times, and other infusion details from the pump back to the EMR, which saves nurses time and may improve hospital reimbursements. This is a win-win for everyone, and we’re proud to partner with Hospira in this advancement of patient care,” Iatric Systems pzrez Frank Fortner said in prepared remarks.

In October, ICU Medical (NSDQ:ICUI) said it agreed to pay $1 billion in cash and stock for the Hospira infusion pump business, confirming rumors that swirled earlier this year that the drug giant was looking to sell the business.

The deal calls for ICU Medical to put up $400 million worth of new shares and $600 million in cash, leaving Pfizer with a 16.6% stake in ICU. The acquisition, expected to close during the 1st quarter of 2017, includes IV pumps, solutions and devices made by the Hospira Infusion Systems business. ICU pegged its pro-forma annual revenues after the deal at roughly $1.45 billion, based on trailing 12-month results as of June.

Supporting regulatory affairs departments to address clinical requirements under new MDR
By Dietmar Falke and Jaap Laufer, Emergo Group The May 25, 2020 MDR deadline is approaching rapidly, and by now many medical device manufacturers are aware that the MDR requires the proactive collection of post-marketing clinical follow-up (PMCF) data. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog… […]
5 tips to raise funding for your medical device
Securing funding can be a long and tedious process, and medical device businesses must work to position themselves as especially attractive to potential investors to maximize success and accelerate the fundraising process. Jon Speer, Greenlight Guru According to Alejandro Cremades, author of The Art of Startup Fundraising, it can take from six to nine months… […]
FDA recognizes latest ISO 14971 as medical device consensus standard
By Mark Leimbeck and Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted Recognized Consensus Standard status to the third edition of the ISO 14071 risk management standard for medical devices and IVD products. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are… […]
Synaptive Medical updates Modus V surgical microscope
Synaptive Medical announced that its U.S. and Canadian Modus V robotic digital microscope now includes updates such as additional 3D visualization and voice-activated control. The Modus V is a robotically controlled digital microscope used as part of Synaptive’s BrightMatter surgical suite designed for less invasive, patient-specific approaches in complex cranial procedures. The Modus V provides similar… […]
New machine can preserve donor livers for 1 week
Researchers in Switzerland have built a perfusion machine that can preserve human livers for transplantation for a week or more, potentially slashing the number of donor livers that must be discarded due to time-related deterioration. Existing perfusion technology can preserve a donor liver for up to 24 hours. The team of surgeons, biologists and engineers… […]
Smiths Medical launches Portex tracheostomy tubes and kits
Smiths Medical this week launched its Portex polyvinyl chloride tracheostomy tube and kit portfolio. The new polyvinyl chloride (PVC) tube portfolio has options for a variety of patients, according to the company. “Our goal was to create tracheostomy tubes and kits designed to help clinicians provide the best patient care. We’re excited to offer a variety… […]
FDA clears Cleveland Clinic 3D-printed airway stents
The FDA recently cleared 3D-printed, patient-specific stents developed by a doctor at the Cleveland Clinic. Cleveland Clinic physician Tom Gildea developed the stents to keep open the airways of patients with serious breathing disorders caused by inflammation, trauma, tumors and other masses. Airway stents come in a limited number of sizes and shapes and are… […]
Boston Scientific shares drop on Q4 sales news
Shares in Boston Scientific (NYSE:BSX) dropped 8% this morning on news of disappointing fourth-quarter sales. The company’s preliminary earnings report showed sales for the quarter ended Dec. 31, 2019 coming in at $2.9 billion, below the $2.91 billion that analysts were expecting. The unaudited sales figure represents organic growth of 7.3%, missing the company’s own guidance of… […]
Study: Timing for knee replacement surgeries is off
New research from Northwestern Medicine suggests that patients with knee osteoarthritis are having knee surgery at the wrong time. According to the researchers, 90% of patients who could benefit from knee replacement surgery are waiting too long to have it and 25% of patients who don’t need it are having it prematurely. “People are waiting… […]
TransEnterix wants to use more AI in surgical robotics: Here’s how
TransEnterix (NYSE:TRXC) has filed a 510(k) submission to add an artificial intelligence feature to its robot-assisted surgery system in which the system can automatically move the camera for a surgeon. Surgeons have been able to move the camera on TransEnterix’s Senhance System via eye sensing. But the new Intelligent Surgical Unit would allow a surgeon, for… […]
Diversified Plastics names Kieval to board
Diversified Plastics, a custom plastic-injection molder and digital thermoplastic components manufacturer, said today that it has appointed Robert Kieval to its board of directors. Kieval has more than 25 years of experience at all levels of the medtech industry. The CEO of IMMR, Inc., Kieval previously served as chief scientific and clinical officer at women’s… […]